Navigation Links
Vioxx Settlement Announced
Date:11/9/2007

TAMPA, Fla., Nov. 9 /PRNewswire/ -- After several years of litigation, Merck has agreed to pay $4.85 billion in a settlement over Vioxx. The medication was pulled off the market in 2004 after a clinical trial proved it increased the risks of heart attacks and strokes. It is one of the largest pharmaceutical settlements in history.

James Hoyer Newcomer and Smiljanich is pleased this long process is coming to a resolution. The firm has more than a dozen clients who've suffered the ill-effects of taking Vioxx. "This settlement was a long time coming, but one that will finally give our clients some relief from the harm they suffered," said Attorney John Newcomer.

Nearly 30-thousand lawsuits have been filed nationwide against Merck because of Vioxx. Plaintiffs will receive different settlement payments depending on the severity of their injuries and the length of time they took Vioxx. Plaintiff Alvin Jupiter, of Tampa, suffered a heart attack in 2001 after taking Vioxx. He said, "I'm glad to see something coming to fruition on this. So many people were hurt."

James Hoyer Newcomer & Smiljanich will review details of the settlement over the coming weeks and work to ensure our clients are compensated fairly.


'/>"/>
SOURCE James Hoyer Newcomer & Smiljanich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New study may explain Vioxx side-effects
2. Study Points to Cause of Vioxx Heart Risk
3. Vioxx Ban Tied to Rise in Serious GI Trouble
4. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
5. Vioxx Settlement Puts Painkillers Back in the Spotlight
6. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
7. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
8. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
9. $52.5 Million Settlement Against Sepracor Inc. Approved
10. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
11. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... ... From a health perspective, 2017 will clearly be the Year of the Gut. ... health and general physical well-being. The New York Times suggested a “ Gut Makeover ... Charlottesville restaurant, good gut health is clearly on the menu. Threepenny Cafe ...
(Date:1/18/2017)... ... January 18, 2017 , ... The ... Bioengineering are collaborating on a research project focused on multiple sclerosis (MS). Led ... to use nanotechnology to control the disease without compromising normal immune function that ...
(Date:1/18/2017)... NJ (PRWEB) , ... January ... ... the specialty pharmacy industry’s leading journal and most-read publication among specialty pharmacists ... University Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian ...
(Date:1/18/2017)... Beach, FL (PRWEB) , ... January 18, 2017 , ... ... a fund raiser for Smile Train, an international charity that provides free surgery to ... hobby of mine and in the past I have run to support the efforts ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Portee Insurance Agency, a family managed firm ... central Maryland and the DC region, is inaugurating a charity event aimed at fighting ... year, making it the #1 killer in America. However, heart disease is largely preventable, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... CAMBRIDGE, England , January 19, 2017 ... MedImmune and Otsuka in the Milner Therapeutics Consortium   ... academic scientists in Cambridge   ... Inc. (NYSE: PFE ) as a partner ... join the Consortium, which enables the efficient transfer of ...
(Date:1/19/2017)... , January 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in ... Wound care is $2 5 ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ... - Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia for ...
Breaking Medicine Technology: